An ISO 9001, 14001, 45001 certified company sales@bldpharm.com
Currency :
Language : English |
Location :
Location
  • Americas
    • Europe
      • Asia Pacific
        • Africa & Middle East
          |

          Products(101) Items 1-5 of 3

          N-(2,6-Di(naphthalen-1-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1226907-33-0 97%

          (11bR)-N-(2,6-Di([1,1'-biphenyl]-4-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1071853-94-5 97%

          (11bS)-1,1,1-Trifluoro-N-(4-oxido-2,6-di(pyren-1-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          1372790-39-0 97%

          (11bR)-N-(2,6-Bis(4-nitrophenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1010799-99-1 97%

          (11bR)-1,1,1-Trifluoro-N-(4-oxido-2,6-di(phenanthren-9-yl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          1181834-74-1 97+%

          (11BR)-N-(2,6-di(naphthalen-2-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1010800-01-7 97%

          (11bR)-1,1,1-Trifluoro-N-(4-oxido-2,6-di(pyren-4-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          N/A 97%

          (11BR)-N-(2,6-di(naphthalen-1-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1010800-00-6 97%

          2,6-Bis(3,5-bis(trifluoromethyl)phenyl)dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine- 3,3,5,5-tetraoxide-(11bR)-

          1174193-01-1 98%

          (11bS)-N-(2,6-Di(naphthalen-1-yl)-4-oxido-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          98%

          (S)-N-(2,6-Bis(4-(tert-butyl)phenyl)-4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          1643958-21-7 97+%

          N-((11BS)-2,6-bis(4-(naphthalen-2-yl)phenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          N/A 97+%

          (S)-1,1,1-Trifluoro-N-(4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          2304917-54-0 97+%

          (11BS)-2,6-Bis[3,5-bis(trifluoromethyl)phenyl]dinaphtho[2,1-d:1′,2′-f][1,3,2]dithiazepine 3,3,5,5-tetraoxide

          1242421-77-7 98%

          (11BR)-2,6-bis(4-(trifluoromethyl)phenyl)-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine 3,3,5,5-tetraoxide

          1245748-56-4 98+%

          1,1,1-Trifluoro-N-(4-oxido-2,6-diphenyldinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          98%

          1,1,1-Trifluoro-N-(4-oxido-2,6-bis(2,4,6-triisopropylphenyl)-8,9,10,11,12,13,14,15-octahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          98%

          (S)-N-(2,6-Di([1,1'-biphenyl]-4-yl)-4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          97+%

          (R)-1,1,1-Trifluoro-N-(4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          1604706-75-3 97+%

          (S)-N-(2,6-Di([1,1':3',1''-terphenyl]-5'-yl)-4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          97+%

          N-((11BR)-2,6-bis(4-(naphthalen-2-yl)phenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          N/A 97+%

          (11BS)-2,6-bis(4-(trifluoromethyl)phenyl)-4H-dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine 3,3,5,5-tetraoxide

          1644388-85-1 98%

          (S)-N-(2,6-Di(naphthalen-2-yl)-4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          97+%

          N-(2,6-Bis(3,5-bis(trifluoromethyl)phenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamid

          1836233-61-4 98%

          (S)-N-(2,6-Bis(3,5-dimethylphenyl)-4-oxido-7a,8,9,10,11,11a,12,13,14,15-decahydrodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)-1,1,1-trifluoromethanesulfonamide

          97+%

          1,1,1-Trifluoro-N-[(11bS)-8,9,10,11,12,13,14,15-octahydro-4-oxido-2,6-bis[2,4,6-trisisopropylphenyl]dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]methanesulfonamide

          98%

          (11bS)-2,6-diphenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'f][1,3,2]dithiazepine

          1384452-66-7 98%

          (11bS)-1,1,1-Trifluoro-N-(4-oxido-2,6-di(pyren-4-yl)dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl)methanesulfonamide

          1450764-53-0 98%

          (11bS,11'bS)-4,4'-dioxide-4,4'-iminobis[8,9,10,11,12,13,14,15-octahydro-2,6-Bis(3,5-dimethylphenyl)-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

          98%

          N-[(11bR)-2,6-Bis(3,5-dimethylphenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide

          98%

          N-[(11bS)-2,6-Bis(3,5-dimethylphenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide

          98%

          (11bR)-2,6-di-2-naphthalenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          1245748-55-3 98%

          (11bS)-2,6-diiodo-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          1810874-47-5 98%

          (11bR)-2,6-di-1-naphthalenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          1245748-65-5 98%

          (11bS)-9,10,11,12,13,14,15-octahydro-2,6-di-2-naphthalenyl-N-?[(11bS)-8,9,10,11,12,13,14,15-octahydro-2,6-di-2-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]?dioxaphosphepin-4-yl]-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine

          98%

          N-[(11bS)-2,6-bis([1,1'-biphenyl]-4-yl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide

          2222149-77-9 98%

          2,6-diphenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'f][1,3,2]dithiazepine

          1384452-64-5 98%

          (11bS)-2,6-di-2-naphthalenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          98%

          (11bR)-2,6-diphenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'f][1,3,2]dithiazepine

          1245748-54-2 98%

          (11bS)-9,10,11,12,13,14,15-octahydro-2,6-di-1-naphthalenyl-N-?[(11bS)-8,9,10,11,12,13,14,15-octahydro-2,6-di-1-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]?dioxaphosphepin-4-yl]-4,4'-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine

          98%

          S-3,3'-Dibromo-1,1'-Binaphthalene-2,2'-sulfonimide

          1461735-85-2 98%

          N-[Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide triethylamine adduct

          1150111-92-4 98%

          N-[(11bS)-2,6-di-2-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide

          98%

          (11bR)-9,10,11,12,13,14,15-octahydro-2,6-di-2-naphthalenyl-N-?[(11bR)-8,9,10,11,12,13,14,15-octahydro-2,6-di-2-naphthalenyl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]?dioxaphosphepin-4-yl]-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine

          1638840-40-0 98%

          (11bR)-2,6-diiodo-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          1245748-53-1 98%

          (11bS)-9,10,11,12,13,14,15-octahydro-2,6-di-9-Phenanthryl-N-[(11bS)-8,9,10,11,12,13,14,15-octahydro-2,6-di-9-Phenanthryl-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-4-oxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-amine

          N/A 98%

          N-[(11BR)-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoromethanesulfonamide triethylamine adduct

          98%

          (11bS)-2,6-di-1-naphthalenyl-3,3,5,5-tetraoxide-Dinaphtho[2,1-d:1',2'-f][1,3,2]dithiazepine

          98%

          N-[(11bS)-2,6-bis(4-nitrophenyl)-4-oxidodinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin-4-yl]-1,1,1-trifluoro-Methanesulfonamide

          1628940-60-2 98%

          (11bR,11'bR)-4,4'-dioxide-4,4'-iminobis[8,9,10,11,12,13,14,15-octahydro-2,6-diphenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin

          1638840-38-6 98%

          1 2 3 Total of 3 Pages